[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]
NCT07389304 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-02-05
Summary
This study is a Phase I randomized clinical trial aiming to investigate the short-term effects of three commonly prescribed statins i.e (Atorvastatin, Rosuvastatin, and Simvastatin) at different dose levels i.e lo,median and high doses on cardiovascular parameters i.e Blood pressure and ECG morphology in healthy volunteers. The study will assess changes in blood pressure and ECG morphology following two days of statin administration under controlled conditions.
Conditions
- Lipid Profile,Blood Pressure
Interventions
- DRUG
-
Rosuvastatin (5mg, 20mg, 40mg)
The Rosuvastatin (5mg, 20mg, 40mg) group participants will be given the drug orally OD for two days
- DRUG
-
Atorvastatin (10mg, 20mg, 40mg)
The Atorvastatin (10mg, 20mg, 40mg) group participants will be given the drug orally OD for two days
- DRUG
-
Simvastatin (10mg, 20mg, 40m
The Simvastatin (10mg, 20mg, 40mg) group participants will be given the drug orally OD for two days
Sponsors & Collaborators
-
Khyber Medical University Peshawar
collaborator OTHER -
Shaheed Benazir Bhutto University Sheringal Dir Upper
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-03-01
- Primary Completion
- 2026-12-30
- Completion
- 2027-02-20
Countries
- Pakistan
Study Locations
More Related Trials
-
Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
NCT06053983 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
NCT06834932 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI
NCT06924684 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
NCT00574782 ·Status: COMPLETED
-
Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia
NCT00683618 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study Between Antihyperlipidemic Agents in Treatment of Cardiovascular Diseases
NCT07313124 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Crestor Versus Placebo in Subjects With Heart Failure
NCT00206310 ·Status: COMPLETED ·Phase: PHASE3
-
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
NCT01352897 ·Status: COMPLETED
-
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
NCT00296400 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease
NCT00296374 ·Status: COMPLETED ·Phase: PHASE2
-
To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia
NCT00726362 ·Status: COMPLETED
-
A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
NCT01138072 ·Status: COMPLETED ·Phase: PHASE1
-
Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome
NCT05306990 ·Status: COMPLETED ·Phase: NA
-
A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
NCT00240318 ·Status: COMPLETED ·Phase: PHASE3
-
Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients
NCT07254221 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges
NCT00654537 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Interaction Statin
NCT02089061 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)
NCT00396110 ·Status: COMPLETED
-
Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy
NCT00951132 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of Rosuvastatin Therapy on HDL2 Level
NCT02593487 ·Status: UNKNOWN ·Phase: PHASE4
-
A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
NCT02979704 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers
NCT02289430 ·Status: COMPLETED ·Phase: PHASE1
-
Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines
NCT00240292 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients
NCT00631189 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
NCT06186037 ·Status: RECRUITING ·Phase: PHASE4